ÂÜÀòÂÒÂ×

Christina Fleet is an accomplished scientist with extensive experience in drug discovery and molecular biology. Currently serving as a Scientist I at Biogen Idec since May 2013, Christina contributes to advancing therapeutic developments. Christina previously worked at AVEO Oncology as an Associate Scientist in Drug Discovery (2007-2012) and as a Senior Research Associate (2005-2007), playing a key role in developing antibody drug candidates and conducting essential project work leading to IND filings and phase I clinical trials. At Brigham and Women's Hospital, Christina focused on studying the tumor suppressor NF1. Prior roles include significant contributions to gene therapy research at Genetix Pharmaceuticals and foundational work in molecular diagnostics at Massachusetts General Hospital. Christina holds a B.A. from Saint Anselm College.